Question 1

Does Guggenheim Capital own MRNA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Guggenheim Capital holds 55,313 shares of MRNA (Moderna), worth $3.9M.

Question 2

How many shares of MRNA does Guggenheim Capital own?

Accepted Answer

As of its Q2 2026 13F, Guggenheim Capital holds 55,313 shares of MRNA (Moderna).

Question 3

What is Guggenheim Capital's MRNA position worth?

Accepted Answer

As of its Q2 2026 13F, Guggenheim Capital's MRNA position is worth $3.9M.

Question 4

Is Guggenheim Capital buying or selling MRNA?

Accepted Answer

In Q2 2026, Guggenheim Capital reduced its MRNA position by 774 shares (-1.4%).

Question 5

When did Guggenheim Capital first buy MRNA?

Accepted Answer

Guggenheim Capital first reported MRNA in its Q2 2020 13F and has listed it in 25 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	55,313	-1.4%	$3.9M	0.0%	$70.03	0
2026-Q1	Decreased	56,087	-14.1%	$2.8M	0.0%	$49.83	0
2025-Q4	Increased	65,325	+4.1%	$1.9M	0.0%	$30.41	27
2025-Q3	Increased	62,727	+2.8%	$1.6M	0.0%	$25.33	26
2025-Q2	Increased	61,050	+10.9%	$1.7M	0.0%	$27.16	29
2025-Q1	Increased	55,028	+2.6%	$1.6M	0.0%	$31.12	26
2024-Q4	Decreased	53,633	-62.9%	$2.2M	0.0%	$39.38	0
2024-Q3	Increased	144,688	+10.0%	$9.7M	0.1%	$65.75	30